VCEL - Vericel Corp
34.96
0.570 1.630%
Share volume: 536,235
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$34.39
0.57
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 07-31-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 356.661 M | 376.839 M | 390.405 M | 432.722 M | 424.587 M | 435.608 M | 453.274 M | 487.969 M | |
| Current Assets | 189.718 M | 197.386 M | 190.520 M | 212.777 M | 197.640 M | 204.577 M | 221.967 M | 247.437 M | |
| Inventories | 13.557 M | 14.887 M | 15.756 M | 17.373 M | 17.106 M | 16.831 M | 18.155 M | 17.560 M | |
| Other Current Assets | 7.775 M | 6.432 M | 7.882 M | 7.287 M | 8.518 M | 6.575 M | 8.006 M | 7.744 M | |
| Short Term Investments | 7.775 M | 6.432 M | 48.053 M | 41.693 M | 39.412 M | 36.349 M | 34.977 M | 37.407 M | |
| Total Receivables | 49.934 M | 47.996 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 110.648 M | 102.508 M | 53.681 M | 74.520 M | 73.490 M | 80.532 M | 100.403 M | 100.092 M | |
| Total Non-current Assets | 166.943 M | 179.453 M | 32.895 M | 39.880 M | 43.342 M | 47.400 M | 49.664 M | 61.395 M | |
| Property Plant Equipment | 56.392 M | 73.086 M | 88.413 M | 103.161 M | 108.294 M | 109.848 M | 109.380 M | 108.397 M | |
| Other Assets | 717.000 K | 664.000 K | 111.472 M | 116.784 M | 118.653 M | 121.183 M | 121.927 M | 132.135 M | |
| Intangible Assets | 6.719 M | 6.563 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 356.661 M | 376.839 M | 390.405 M | 432.722 M | 424.587 M | 435.608 M | 453.274 M | 487.969 M | |
| Total liabilities | 122.765 M | 133.862 M | 132.933 M | 140.755 M | 129.100 M | 128.799 M | 131.416 M | 133.329 M | |
| Total current liabilities | 36.470 M | 43.863 M | 41.346 M | 50.286 M | 39.448 M | 41.132 M | 45.582 M | 49.149 M | |
| Accounts Payable | 19.432 M | 25.216 M | 20.884 M | 23.848 M | 16.751 M | 12.857 M | 15.335 M | 15.828 M | |
| Other liabilities | 154.000 K | 198.000 K | 91.587 M | 90.469 M | 89.652 M | 87.667 M | 85.834 M | 84.180 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 154.000 K | 198.000 K | 91.587 M | 90.469 M | 89.652 M | 87.667 M | 85.834 M | 84.180 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 233.896 M | 242.977 M | 257.472 M | 291.967 M | 295.487 M | 306.809 M | 321.858 M | 354.640 M | |
| Common stock | 48.141 M | 48.686 M | 669.735 M | 684.778 M | 699.412 M | 711.240 M | 721.140 M | 730.662 M | |
| Retained earnings | -407.039 M | -411.721 M | -412.622 M | -392.815 M | -404.061 M | -404.614 M | -399.540 M | -376.297 M |